OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Pharmaceutics is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial Board	991
Levilactobacillus brevis surface layer protein B promotes liposome targeting to antigen-presenting cells in Peyer’s patches	730
Effect of the combination of permeation enhancer and ion-pairs strategies on transdermal delivery of tofacitinib	235
Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies	177
Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites	163
Development of purified glycogen derivatives as siRNA nanovectors	126
Editorial Board	123
Practical use of primary drying models in an industrial environment with limited availability of equipment sensors	121
Benzoic acid complexes with Eudragit E100®: New alternative antimicrobial preservatives	118
In vivo methodologies to assist preclinical development of topical fixed-dose combinations for pain management	118
Design of red blood cell membrane-cloaked dihydroartemisinin nanoparticles with enhanced antimalarial efficacy	114
Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: Anti-hepatocellular carcinoma and reduced hepatotoxicity	102
Corrigendum to article “Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies” [Int. J. Pharm. 431(1–2) (2012	98
Corrigendum to “Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow” [Int. J. Pharm. 659 (2024) 124246]	98
Switching from batch to continuous granulation: A case study of metoprolol succinate ER tablets	92
Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization	91
Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure	87
Corrigendum to “Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers” [Int. J. Pharm. 604 (2021) 120755]	84
Corrigendum to “Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect” [Int. J. Pharm. 652 (2024) 123802]	83
Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids	80
Biomimetic replenishment therapy of cortisol using semi-solid extrusion – 3D printed tablets for adrenal insufficiencies	80
Mast cell activators as adjuvants for intranasal mucosal vaccines	80
4D study of liquid binder penetration dynamics in pharmaceutical powders using synchrotron X-ray micro computed tomography	79
Kidney-accumulating olmesartan-loaded nanomicelles ameliorate the organ damage in a murine model of Alport syndrome	78
Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis	74

In vivo and in vitro transdermal availability of Ibuprofen using novel solubility enhancing fluid nanosized carrier systems	72
Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement	71
Elastic cationic liposomes for vitamin C delivery: Development, characterization and skin absorption study	70
Vesicular phospholipid gels: A new strategy to improve topical antimicrobial dermatotherapy	69
A quantification of gastric and duodenal fluid volumes in older adults using MRI	69
Probing fluconazole deposition inside mesoporous silica using solid-state NMR spectroscopy: Crystallization of a confined metastable form and phase transformations under storage conditions	67
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration	67
From laminar to turbulent flow in a dry powder inhaler: The effect of simple design modifications	66
Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration	64
A framework to optimize spring-driven autoinjectors	64
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii	64
Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats	64
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine	64
Wet granulation end point prediction using dimensionless numbers in a mixer torque rheometer: Relationship between capillary and Weber numbers and the optimal wet mass consistency	63
A straw for paediatrics: How to administer highly dosed, bitter tasting paracetamol granules	63
Synthesis of manganese-incorporated polycaplactone-poly (glyceryl methacrylate) theranostic smart hybrid polymersomes for efficient colon adenocarcinoma treatment	63
Evaluation of a polymeric topical formulation of Endoxifen in an estrogen receptor positive breast cancer murine model	62
Protective role of transforming growth factor-Β3 (TGF-Β3) in the formation of radiation-induced capsular contracture around a breast implant: In vivo experimental study	61
Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis	60
Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)	60
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution	59
Hydrogel-forming microarray patches combined with powder-based reservoir for labetalol hydrochloride transdermal delivery	59
Comparative dissolution studies of 3D-printed inserts in a novel biopharmaceutical bladder model	59
Editorial Board	59
Polymer-inducing chemical degradation of amorphous solid dispersions driven by drug-polymer interactions for physical stabilization	59
Production and characterization of bovine hoof membranes as standardized in vitro model for nail studies	58
Editorial Board	57
Quality by design – Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation	57
In situ gel-forming oil as rectally delivering platform of hydrophobic therapeutics for ulcerative colitis therapy	55
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions	55